We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJO

This study has been withdrawn prior to enrollment.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00199472
First Posted: September 20, 2005
Last Update Posted: August 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
St. Joseph's Health Care London
General Electric
Information provided by (Responsible Party):
Lawson Health Research Institute
  Purpose
Renal blood flow is inversely related to obstruction. We propose that this imaging will be as effective as the diuretic renogram in the functional diagnosis of obstruction. Furthermore, dynamic contrast CT scanning may also add anatomic information necessary for the surgical treatment.

Condition Intervention
Ureteral Obstruction Procedure: Dynamic Contrast Enhanced CT & Diuretic Renogram

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of Ureteropelvic Junction Obstruction

Further study details as provided by Lawson Health Research Institute:

Enrollment: 0
Study Completion Date: June 2001
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or older;
  • Subjects suspected to have UPJO.

Exclusion Criteria:

  • Pregnancy;
  • Renal failure (Creatinine >150);
  • Allergy to contrast material;
  • Ureteral stent;
  • Nephrostomy tube;
  • Renal pelvis calculi.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00199472


Locations
Canada, Ontario
Urology Clinic, St. Joseph's Hospital, St. Joseph's Health Care London
London, Ontario, Canada, N6A 4V2
Sponsors and Collaborators
Lawson Health Research Institute
St. Joseph's Health Care London
General Electric
Investigators
Principal Investigator: John D Denstedt, MD, FRCSC Urology, St. Joseph's Hospital, University of Western Ontario
  More Information

Responsible Party: Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT00199472     History of Changes
Other Study ID Numbers: 07378
First Submitted: September 13, 2005
First Posted: September 20, 2005
Last Update Posted: August 25, 2017
Last Verified: August 2017

Additional relevant MeSH terms:
Ureteral Obstruction
Ureteral Diseases
Urologic Diseases
Diuretics
Natriuretic Agents
Physiological Effects of Drugs